Center for Epithelial and Airway Biology and Regeneration

Search results

• Dr. Richard Henry "Dick" Gross

  Kim, B.

  16/04/25

  1 item of Media coverage

  Press/Media

• Weekly: Kalvista Pharmaceuticals (KALV: $11.49) gains 7% on robust volume, Cash Runway of 11 months; +78c [7.3%] Vol Index 1.8 [1 is avg]

  Busse, P.

  12/04/25

  1 item of Media coverage

  Press/Media

• Kalvista Pharmaceuticals continues uptrend, jumps 24% and in top 4% of the market

  Busse, P.

  11/04/25

  1 item of Media coverage

  Press/Media

• Kalvista Pharmaceuticals strengthens 1% in past year

  Busse, P.

  7/04/25

  1 item of Media coverage

  Press/Media

• Weekly: Kalvista Pharmaceuticals (KALV: $10.71) tumbles 10% on high volume, Cash Runway of 11 months; -$1.22 [10.2%] Vol Index 1.9 [1 is avg]

  Busse, P.

  5/04/25

  1 item of Media coverage

  Press/Media

• Brian Brown, Ph.D., Joins AIMBE College for Gene Therapy Breakthroughs

  Brown, B. & Charney, D.

  1/04/25

  1 item of Media coverage

  Press/Media

• 100 Best & Brightest Undergraduate Business Majors Of 2025

  Kim, B.

  1/04/25

  1 item of Media coverage

  Press/Media

• Brian Brown, PhD, Inducted Into AIMBE College of Fellows for Pioneering Contributions in Gene Therapy and Functional Genomics

  Brown, B. & Charney, D.

  31/03/25

  2 items of Media coverage

  Press/Media

• Brian Brown, Ph.D., Honored with Induction into AIMBE College of Fellows for Groundbreaking Work in Gene Therapy and Functional Genomics

  Brown, B.

  31/03/25

  2 items of Media coverage

  Press/Media

• Weekly: Kalvista Pharmaceuticals (KALV: $11.93) increases on firm volume, Cash Runway of 11 months; +4c [0.3%]

  Busse, P.

  29/03/25

  1 item of Media coverage

  Press/Media

• Alys Pharmaceuticals Announces Dosing of First Patient in Phase IIa Trial of ALY-101 for Alopecia Areata

  Kim, B.

  27/03/25

  2 items of Media coverage

  Press/Media

• Alys Pharmaceuticals Announces Dosing of First Patient in Phase IIa Trial of ALY-101 for Alopecia Areata

  Kim, B.

  27/03/25

  71 items of Media coverage

  Press/Media

• Alys Pharmaceuticals Announces Dosing of First Patient in Phase IIa Trial of ALY-101 for Alopecia Areata

  Kim, B.

  27/03/25

  1 item of Media coverage

  Press/Media

• Research identifies pressure-sensing protein behind gut motility

  Kim, B.

  25/03/25

  1 item of Media coverage

  Press/Media

• Investigators at Hebei General Hospital Discuss Findings in Sodium-Glucose Transporter 2 Inhibitors (Canagliflozin Ameliorates Ferritinophagy In Hfpef Rats)

  Ma, S.

  25/03/25

  1 item of Media coverage

  Press/Media

• Study identifies gut sensor that propels intestines to move

  Kim, B. & Hu, H.

  24/03/25

  2 items of Media coverage

  Press/Media

• Mount Sinai Researchers Identify Key Gut Sensor That Regulates Digestion and Immunity

  Lebwohl, M., Kim, B. & Hu, H.

  24/03/25

  1 item of Media coverage

  Press/Media

• Mount Sinai Researchers Identify Key Gut Sensor That Regulates Digestion and Immunity

  Lebwohl, M., Kim, B. & Hu, H.

  24/03/25

  1 item of Media coverage

  Press/Media

• Weekly: Kalvista Pharmaceuticals (KALV: $11.89) falls 6% on firm volume, Cash Runway of 11 months; -71c [5.6%] Vol Index 1.3 [1 is avg]

  Busse, P.

  22/03/25

  1 item of Media coverage

  Press/Media

• New Findings Reported from Dalian University of Technology Describe Advances in Mathematics (Optimization Methods of Carbon Fiber Composite Antenna Surface Precision Based On Genetic Algorithms)

  Ma, S.

  20/03/25

  1 item of Media coverage

  Press/Media

• Weekly: Kalvista Pharmaceuticals (KALV: $12.60) keeps rising: up 61% in 9 weeks; +68c [5.7%]

  Busse, P.

  15/03/25

  1 item of Media coverage

  Press/Media

• Kalvista Pharmaceuticals continues uptrend, surges 45% and in top 3% of the market

  Busse, P.

  14/03/25

  1 item of Media coverage

  Press/Media

• Expert Perspectives: Dermatology's Top Story to Watch in 2025

  Lebwohl, M. & Kim, B.

  12/03/25

  2 items of Media coverage

  Press/Media

• Expert Perspectives: Dermatology's Top Story to Watch in 2025; A group of 9 experts reflect on what they are looking forward to most in 2025 following the AAD annual meeting.

  Lebwohl, M. & Kim, B.

  12/03/25

  1 item of Media coverage

  Press/Media

• Advances in Understanding of Itch: A Conversation with Brian S Kim, MD, MTR, at the 2025 AAD Meeting; Brian S Kim, MD, a leading investigator in the study of itch physiology, discusses the marked progress made in understanding the sensation and targeting

  Lebwohl, M. & Kim, B.

  12/03/25

  1 item of Media coverage

  Press/Media